COMMD1-Deficient Dogs Accumulate Copper in Hepatocytes and Provide a Good Model for Chronic Hepatitis and Fibrosis

New therapeutic concepts developed in rodent models should ideally be evaluated in large animal models prior to human clinical application. COMMD1-deficiency in dogs leads to hepatic copper accumulation and chronic hepatitis representing a Wilson’s disease like phenotype. Detailed understanding of the pathogenesis and time course of this animal model is required to test its feasibility as a large animal model for chronic hepatitis. In addition to mouse models, true longitudinal studies are possible due to the size of these dogs permitting detailed analysis of the sequence of events from initial insult to final cirrhosis. Therefore, liver biopsies were taken each half year from five new born COMMD1-deficient dogs over a period of 42 months. Biopsies were used for H&E, reticulin, and rubeanic acid (copper) staining. Immunohistochemistry was performed on hepatic stellate cell (HSC) activation marker (alpha-smooth muscle actin, α-SMA), proliferation (Ki67), apoptosis (caspase-3), and bile duct and liver progenitor cell (LPC) markers keratin (K) 19 and 7. Quantitative RT-PCR and Western Blots were performed on gene products involved in the regenerative and fibrotic pathways. Maximum copper accumulation was reached at 12 months of age, which coincided with the first signs of hepatitis. HSCs were activated (α-SMA) from 18 months onwards, with increasing reticulin deposition and hepatocytic proliferation in later stages. Hepatitis and caspase-3 activity (first noticed at 18 months) increased over time. Both HGF and TGF-β1 gene expression peaked at 24 months, and thereafter decreased gradually. Both STAT3 and c-MET showed an increased time-dependent activation. Smad2/3 phosphorylation, indicative for fibrogenesis, was present at all time-points. COMMD1-deficient dogs develop chronic liver disease and cirrhosis comparable to human chronic hepatitis, although at much higher pace. Therefore they represent a genetically-defined large animal model to test clinical applicability of new therapeutics developed in rodent models.

[1]  K. Hirata,et al.  Liver repopulation and long‐term function of rat small hepatocyte transplantation as an alternative cell source for hepatocyte transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  M. Finegold,et al.  Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice. , 2006, The American journal of pathology.

[3]  B. Sarkar,et al.  The puzzle posed by COMMD1, a newly discovered protein binding Cu(II). , 2011, Metallomics : integrated biometal science.

[4]  A. Zhernakova,et al.  The canine copper toxicosis gene MURR1 does not cause non-Wilsonian hepatic copper toxicosis. , 2003, Journal of hepatology.

[5]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[6]  T. Roskams.  Different types of liver progenitor cells and their niches. , 2006, Journal of hepatology.

[7]  C. Wijmenga,et al.  A novel role for XIAP in copper homeostasis through regulation of MURR1 , 2004, The EMBO journal.

[8]  P. Galle,et al.  Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1 /Fas) Mediated apoptosis , 1998, Nature Medicine.

[9]  S. Packman,et al.  An international symposium on Wilson's and Menkes' diseases , 1996, Hepatology.

[10]  M. Reiss,et al.  Smads 2 and 3 are differentially activated by TGF-β in quiescent and activated hepatic stellate cells: Constitutive nuclear localization of Smads in activated cells is TGF-β independent , 2003 .

[11]  T. Roskams,et al.  Transforming growth factor β‐1 signalling in canine hepatic diseases: new models for human fibrotic liver pathologies , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[12]  T. Roskams,et al.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.

[13]  L. Penning,et al.  Development and evaluation of canine reference genes for accurate quantification of gene expression. , 2006, Analytical biochemistry.

[14]  J. Iredale.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. , 2007, The Journal of clinical investigation.

[15]  V. Paradis,et al.  Liver extracellular matrix in health and disease , 2003, The Journal of pathology.

[16]  C. Wijmenga,et al.  Identification of a new copper metabolism gene by positional cloning in a purebred dog population. , 2002, Human molecular genetics.

[17]  S. Thorgeirsson,et al.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Peppercorn,et al.  The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.

[19]  T. Cantz,et al.  Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? , 2008, Gut.

[20]  L. Penning,et al.  Quantitative PCR method to detect a 13-kb deletion in the MURR1 gene associated with copper toxicosis and HIV-1 replication , 2005, Mammalian Genome.

[21]  S. Virgiliis,et al.  The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease , 2006, Journal of Gastroenterology.

[22]  C. Wijmenga,et al.  Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. , 2007, Gastroenterology.

[23]  G. Michalopoulos,et al.  Liver Regeneration , 1997, Science.

[24]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[25]  S. Forbes,et al.  Activation of stem cells in hepatic diseases , 2007, Cell and Tissue Research.

[26]  C. Wijmenga,et al.  Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation , 2011, PloS one.

[27]  H. Nederbragt,et al.  Tenascin-C in Chronic Canine Hepatitis: Immunohistochemical Localization and Correlation with Necro-Inflammatory Activity, Fibrotic Stage, and Expression of Alpha-Smooth Muscle Actin, Cytokeratin 7, and CD3+ Cells , 2007, Veterinary pathology.

[28]  G. Hoffmann,et al.  Copper-associated chronic hepatitis in Labrador Retrievers. , 2006, Journal of veterinary internal medicine.

[29]  R. Hardy,et al.  A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans. , 1982, The American journal of physiology.

[30]  L. Penning,et al.  Functional consequences of RNA interference targeting COMMD1 in a canine hepatic cell line in relation to copper toxicosis. , 2007, Animal genetics.

[31]  T. Roskams,et al.  Liver regeneration in acute severe liver impairment: a clinicopathological correlation study , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[32]  C. Wijmenga,et al.  The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis. , 2003, Journal of hepatology.

[33]  C. Wijmenga,et al.  The Copper Toxicosis Gene Product Murr1 Directly Interacts with the Wilson Disease Protein* , 2003, Journal of Biological Chemistry.

[34]  T. Roskams,et al.  Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours , 2010, Comparative hepatology.

[35]  J. Cullen,et al.  Chapter 7 – Morphological classification of parenchymal disorders of the canine and feline liver: 2. Hepatocellular death, hepatitis and cirrhosis , 2006 .

[36]  S. Forbes,et al.  Hepatic fibrogenesis: from within and outwith. , 2008, Toxicology.

[37]  T. V. D. van den Ingh,et al.  Chronic active hepatitis with cirrhosis in the Doberman pinscher. , 1988, The Veterinary quarterly.

[38]  T. Roskams,et al.  Cross‐species immunohistochemical investigation of the activation of the liver progenitor cell niche in different types of liver disease , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[39]  Jean S. Campbell,et al.  Liver regeneration. , 2012, Journal of hepatology.